Emerson Electric (EMR) is an industrial conglomerate operating in five primary business segments: Process Management (31% of sales), Industrial Automation, Network Power, Climate Technologies, and Commercial & Residential Solutions. The company generated about 45% of revenues in the U.S. and Canada during F2012, with another 24% from Asia, 20% from Europe, 6% from Latin America, and the remainder from the Middle East and Africa. Process management (31% of sales) process management software and systems, analytical instrumentation, valves, control systems for measurement and control of fluid flow, and integrated solutions for process and industrial applications. Industrial automation (21% of sales) makes industrial motors and drives, transmissions, alternators and controls for automated equipment. Network power (25% of sales) makes power systems and precision cooling products used in computer, telecommunications and Internet infrastructure sold mainly to large data centers. Climate technologies (15% of sales) makes home and building thermostats and compressors (cooling components used in heating and air conditioning units and refrigerators). Commercial and residential solutions (7% of sales) makes various household appliances, hand held tools, piping and other related equipment, and storage solutions used in various industries.
EMR Basic Company Stats
- Ticker Symbol: EMR
- PE Ratio: 17.42
- Yield: 3.0%
- % above 52 week low: 70.3%
- Beta: 1.36
- Market cap: $39.67 B
- Website: www.emerson.com
EMR vs the S&P500 over 10 years
EMR has generally exceeded the S&P500 over the last 10 years. Over that time, an investment in EMR would have grown by 113% compared to the 64% that an investment in the S&P500 would have grown. Capital gains almost double that of the S&P500 is pretty solid performance.
EMR Earnings Per Share (EPS) & Dividend Growth
- 1 year EPS growth: -17.6%
- 3 year EPS growth: 1.1%
- 5 year EPS growth: -3.7%
- 10 year EPS growth: -9.2%
EPS growth for EMR was generally upwards until 2009 when it started falling due to the recession. Then EPS growth continued its upward trend until 2012 where it dipped again.
- 1 year dividend growth: 15.9%
- 3 year dividend growth: 9.3%
- 5 year dividend growth: 7.5%
- 10 year dividend growth: 8.2%
Dividend growth for EMR has been great. 8.2% over 10 years is pretty solid growth for an established company like EMR. And if we look at the 1, 3, and 5 year dividend growth it looks like its accelerating. Another good sign for a dividend investor.
With a starting yield of 3.0% and a growth rate of about 8%, EMR’s yield on cost will grow to well in excess of 6.5% in 10 years. In order to double the dividend, using the rule of 72, it will take less than 9 years.
EMR Payout Ratio
EMR’s payout ratio seems to fluctuate from the high 30′s% to the mid 60′s%. The average payout ratio is 50% which seems to be in line with graph above.
EMR Cash Flow & Revenue Growth
- 1 year revenue growth: 0.8%
- 3 year revenue growth: 7.7%
- 5 year revenue growth: -0.4%
- 10 year revenue growth: 6.4%
EMR’s cash flow per share has been inconsistent, but generally displays an upwards trend. Revenue growth has also been similarly inconsistent but upwards. Given that EMR operates in the industrial sector, it’s revenue, cash flow, and earnings are sensitive to economic conditions.
EMR Balance Sheet
The current debt to equity ratio for EMR is about 37%. The debt to equity ratio has hovered around this level for the last 10 years as well going as low as 26% and as high as 58%. Overall, I don’t see any problems here.
The main risks facing EMR at the moment are related to the general slowness of the economic recovery. EMR has been investing a lot in emerging markets, but unless the economy as a whole shrugs off it’s anemic growth it will take a while for these investments to see the kinds of returns that they are capable of. Furthermore, if we get caught in a new recession it’s reasonable to expect EMR’s revenue to drop as the kinds of large scale industrial equipment that they make are some of the first things to be cut back on as business conditions worsen.
EMR Valuation Panel
The Graham number represents one very simple way to value a stock. The Graham number for EMR is $30.45. The stock price is higher than the Graham number, suggesting that EMR may be overvalued valued at the moment.
Two Stage Dividend Discount Model
Using a risk free rate of 2%, an expected return of 10% and the beta of 1.36, the CAPM model provides a discount rate of 20.9%. Using a growth rate of 15% for 5 years and a slower growth rate of 7%, the two stage model produced a value of $18.57, suggesting that EMR is overvalued. I also tried this model with a discount rate of 10% and got $84.08, suggesting that EMR is undervalued.
One Stage (Gordon Growth) Dividend Discount Model
Using a growth rate of 10% and the 20.9% discount rate, the one stage model produces a value of $16.58, suggesting EMR is overvalued.
Of the different models tested, EMR ranks as overvalued on 3 out of 4.
EMR Cash Secured Puts
I feel that EMR is currently overvalued and thus won’t recommend initiating a position in the stock at present and wouldn’t recommend selling puts against it either.
I like EMR as a company, but it is current over valued by way of PE ratio and my valuation panel. If the price drops or the valuation otherwise improves, I wouldn’t mind initiating a position in EMR.
Disclosure: Nothing to disclose.
Readers: What are your opinions about Emerson Electric?